Multiple Stargardt Contenders Progress In Japan Despite Small Market

Medical Need, Supportive Regulations

 
• By Lisa Takagi
  
Japan has two P3 candidates for Stargardt's Disease.
Japan has two candidates for Stargardt in Phase III, despite small local market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia